Blockade of muscarinic transmission increases the frequency of diabetes after low-dose alloxan challenge in the mouse

Diabetologia

Volumn 39, Issue 4, 1996, Pages 383-390

  Ahren, B ^a   Sundkvist, G ^a   Mulder, H ^b   Sundler, F ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Alloxan; Atropine; Cholinergic; Diabetes mellitus; Immunocytochemistry; Insulin gene expression; Insulin secretion; Mouse

Indexed keywords

ALLOXAN; GLUCOSE; INSULIN; MESSENGER RNA; METHYLATROPINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ALLOXAN; ANIMALS; ATROPINE DERIVATIVES; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; INCIDENCE; INSULIN; ISLETS OF LANGERHANS; MICE; MICE, INBRED STRAINS; PARASYMPATHOLYTICS; RNA, MESSENGER;

EID: 0029916546     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050457     Document Type: Article

References (29)

1. Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22: 485-518
2. Lenzen S, Mirzaie-Petri M (1991) Inhibition of glucokinase and hexokinase from pancreatic B-cells and liver by alloxan, alloxantin, dialuric acid, and t-betylhydroperoxide. Biomed Red 12: 297-307
3. Dunn JS, Kirkpatrick J, McLetchie NGB, Telfer SV (1943) Necrosis of the islets of Langerhans produced experimentally. J Pathol Bact 55: 245-257
4. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG (1982) Determinants of the selective toxicity of alloxan on the pancreatic B-cell. Proc Natl Acad Sci USA 79: 927-930
5. Lenzen S, Panten U (1988) Alloxan: history and mechanism of action. Diabetologia 31: 337-342
6. Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozotocin and alloxan induce DNA-strand breaks and poly(ADP-ribose)synthetase in pancreatic islets. Nature 294: 284-285
7. Ahrén B, Sundkvist G (1995) Long-term effects of alloxan in mice. Int J Pancreatol 17: 197-202
8. Ahrén B, Karlsson S, Lindskog S (1990) Cholinergic regulation of the endocrine pancreas. In: Aquilonius S, Gillberg PO (eds) Progress in brain research. Cholinergic neurotransmission, vol 84. Elsevier, Amsterdam, pp 209-218
9. Balkan B, Dunning BE (1995) Muscarinic stimulation maintains in vivo insulin secretion in response to glucose after prolonged hyperglycaemia. Am J Physiol 268:R475-R479
10. N'Guyen JM, Magnan C, Laury MC et al. (1994) Involvement of the autonomic nervous system in the in vivo memory to glucose of pancreatic β cell in rats. J Clin Invest 94: 1456-1462
11. Weiner N (1985) Atropine, scopolamine, and related antimuscarinic drugs. In: Gilman AG, Goodman LS, Rall TW, Murad F (eds) The pharmacological basis of therapeutics. 7th edn. Macmillan, New York, pp 130-144
12. Mulder H, Lindh AC, Sundler F (1993) Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study. Cell Tissue Res 274: 467-474
13. Mulder H, Ahrén B, Stridsberg M, Sundler F (1995) Non-parallelism of islet amyloid polypeptide (amylin) and insulin gene expression in rat islets following dexamethasone treatment. Diabetologia 38: 394-402
14. Coons AH, Leduc EM, Conolly JM (1955) Studies on antibody production. I. A method for the histochemical determination of specific antibodies and its application to a study of the hyperimmune rabbit. J Exp Med 102: 49-59
15. Böttcher G, Ekblad E, Ekman R, Håkanson R, Sundler F (1993) Peptide YY: a neuropeptide in the gut. Immunocytochemical and immunochemical evidence. Neuroscience 55: 281-290
16. Eizirik DL, Sandler S (1989) Function and metabolism of pancreatic β-cells maintained in culture following experimentally induced damage. Pharmacol Toxicol 65: 163-168
17. Bonner-Weir S, Trent DF, Weir GC (1983) Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin secretion. J Clin Invest 71: 1544-1553
18. Rosetti L, Shulman GI, Zawalich W, DeFronzo RA (1987) Effect of chronic hyperglycaemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80: 1037-1044
19. Korsgren O, Jansson L, Andersson A (1989) Effects of hyperglycaemia on function of isolated mouse pancreatic islets transplanted under kidney capsule. Diabetes 38: 510-515
20. Ar'Rajab A, Ahrén B (1993) Long-term diabetogenic effect of streptozotocin in rats. Pancreas 8: 50-57
21. Korsgren O, Jansson L, Sandler S, Andersson A (1990) Hyperglycaemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background. J Clin Invest 86: 2161-2168
22. Gardemann A, Küschel GP, Jungermann K (1992) Nervous control of liver metabolism and hemodynamics. Eur J Biochem 207: 399-411
23. Östenson CG, Grill V (1987) Evidence that hyperglycaemia increases muscarinic binding in pancreatic islets of the rat. Endocrinology 121: 1705-1710
24. Christensen NJ (1979) Catecholamines and diabetes mellitus. Diabetologia 16: 211-224
25. Bergtröm B, Lilja B, Österlin S, Sundkvist G (1990) Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus. Possible influence of obesity. J Int Med 227: 57-63
26. Nilsson H, Bergström B, Lilja B, Juul-Möller S, Carlsson J, Sundkvist G (1995) Prospective study of autonomic nerve function in type 1 and type 2 diabetic patients: 24 hour heart rate variation and plasma motilin levels disturbed in parasympathetic neuropathy. Diabet Med 12: 1015-1021
27. Clauson P, Linnarsson R, Gottsäter A, Sundkvist G, Grill V (1994) Relationships between diabetes duration, metabolic control and β-cell function in a representative population of type 2 diabetic patients in Sweden. Diabet Med 11: 794-801
28. Ahrén B, Taborsky Jr GJ (1986) The mechanism of vagal nerve stimulation of glucagon and insulin secretion in the dog. Endocrinology 118: 1551-1557
29. Karlsson S, Ahrén B (1993) Muscarinic receptor subtypes in carbachol-stimulated insulin and glucagon secretion in the mouse. J Auton Pharmacol 13: 439-446